Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Part of paid clinical trials in New York, New York.
- Sponsor
- The New York Proton Center
- Study ID
- NCT06342284
- Status
- Recruiting
Conditions
- Thoracic Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proton Beam Radiation with or without concurrent chemotherapy — RADIATIONCurative-intent fractionated proton beam thoracic radiotherapy, with or without concurrent chemotherapy
Study Details
This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.
Key Dates
- Start date
- Mar 22, 2024
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 21, 2031
Study Design
- Enrollment
- 40 participants (estimated)
Primary Outcome Measure
Demonstrate the feasibility of patient-generated health data collection during thoracic proton beam radiotherapy for lung cancer, based on the quantity of data collected from the day of radiotherapy initiation to the day of radiotherapy completion. [ Time Frame: 4-5 Weeks ]
Central Contacts
- Nitin Ohri, MD718-405-8550
- Ryan Holder, BS646-968-9055
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York Proton Center | New York | New York | 10035 | Nitin Ohri, MD (PRINCIPAL_INVESTIGATOR) Charles Simone, MD (SUB_INVESTIGATOR) Annemarie Shepherd, MD (SUB_INVESTIGATOR) Stanislav Lazarev, MD (SUB_INVESTIGATOR) Alexandra Hanlon, PhD (SUB_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsRecruiting · The New York Proton Center · New York, New York
- Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsPHASE1/PHASE2 · Recruiting · Tango Therapeutics, Inc. · Scottsdale, Arizona
- SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)Recruiting · Nadine McCleary, MD, MPH · Boston, Massachusetts